A Case of Ceftriaxone-Induced Acute Generalized Exanthematous Pustulosis/Generalized Pustular Psoriasis Overlap
- PMID: 29681811
- PMCID: PMC5903148
- DOI: 10.1159/000488076
A Case of Ceftriaxone-Induced Acute Generalized Exanthematous Pustulosis/Generalized Pustular Psoriasis Overlap
Abstract
Acute generalized exanthematous pustulosis, characterized by subcorneal or superficial intraepidermal pustules, is induced by drugs in more than 90% of cases. Psoriasis is an autoimmune disease triggered by different conditions in genetically susceptible people. Generalized pustular psoriasis is an acute and severe clinical form of psoriasis, which usually occurs in patients with psoriasis undergoing aggravating factors. In this report the authors have reported a 40-year-old male patient with primary syphilis who developed generalized pustular dermatosis after the use of ceftriaxone. On the third day after ceftriaxone treatment, complete regression of the syphilis lesions was reached. While on the sixth day, erythematous pustular lesions accompanied with fever were observed on the whole body. A personal history of psoriasis and histopathological findings with psoriasiform changes and subcorneal pustule favored the diagnosis. After discontinuation of ceftriaxone, the patient's condition slowly improved until he had plaque-type psoriasis 3 weeks later. A heterozygous c.115 + 6T>C missense substitution of IL36RN related to the pathogenesis of acute generalized exanthematous pustulosis/generalized pustular psoriasis was identified.
Keywords: Acute generalized exanthematous pustulosis; Ceftriaxone; Generalized pustular psoriasis; Psoriasis; Syphilis.
Figures



Similar articles
-
Generalized pustular psoriasis induced by systemic steroid dose reduction.An Bras Dermatol. 2016 Sep-Oct;91(5):664-666. doi: 10.1590/abd1806-4841.20163804. An Bras Dermatol. 2016. PMID: 27828647 Free PMC article.
-
Acute Generalized Exanthematous Pustulosis Induced by Hyaluronic Acid Knee Injection: A Case Report.J Emerg Nurs. 2025 Jan;51(1):20-26. doi: 10.1016/j.jen.2024.08.005. J Emerg Nurs. 2025. PMID: 39800444
-
Novel IL36RN mutation in a Japanese case of early onset generalized pustular psoriasis.J Dermatol. 2013 Sep;40(9):749-51. doi: 10.1111/1346-8138.12227. Epub 2013 Jul 9. J Dermatol. 2013. PMID: 23834760
-
The genetic background of generalized pustular psoriasis: IL36RN mutations and CARD14 gain-of-function variants.J Dermatol Sci. 2014 Jun;74(3):187-92. doi: 10.1016/j.jdermsci.2014.02.006. Epub 2014 Mar 5. J Dermatol Sci. 2014. PMID: 24656634 Review.
-
Generalized Pustular Psoriasis, Acute Generalized Exanthematous Pustulosis, and Other Pustular Reactions: A Clinical Review.Dermatol Clin. 2024 Apr;42(2):317-328. doi: 10.1016/j.det.2024.01.001. Dermatol Clin. 2024. PMID: 38423690 Review.
Cited by
-
A Network Analysis of Drug Combinations Associated with Acute Generalized Exanthematous Pustulosis (AGEP).J Clin Med. 2021 Sep 29;10(19):4486. doi: 10.3390/jcm10194486. J Clin Med. 2021. PMID: 34640505 Free PMC article.
-
Drug Triggers and Clinic of Acute Generalized Exanthematous Pustulosis (AGEP): A Literature Case Series of 297 Patients.J Clin Med. 2022 Jan 13;11(2):397. doi: 10.3390/jcm11020397. J Clin Med. 2022. PMID: 35054090 Free PMC article. Review.
-
Acute Generalized Exanthematous Pustulosis: Clinical Features, Differential Diagnosis, and Management.Am J Clin Dermatol. 2023 Jul;24(4):557-575. doi: 10.1007/s40257-023-00779-3. Epub 2023 May 8. Am J Clin Dermatol. 2023. PMID: 37156992 Free PMC article. Review.
References
-
- Sidoroff A, Halevy S, Bavinck JN, Vaillant L, Roujeau JC. Acute generalized exanthematous pustulosis (AGEP) – a clinical reaction pattern. J Cutan Pathol. 2001;28:113–119. - PubMed
-
- Burrows NP, Russell Jones RR. Pustular drug eruption: a histopathological spectrum. Histopathology. 1993;22:569–573. - PubMed
-
- Teraki Y, Tanaka S, Hitomi K, Izaki S. A case of generalized psoriasiform and pustular eruption induced by infliximab: evidence for skin-homing Th17 in the pathogenesis. Br J Dermatol. 2010;163:1347–1351. - PubMed
-
- Onoufriadis A, Simpson MA, Pink AE, Meglio PD, Smith CH, Pullabhatla V, Knight J, Spain SL, Nestle FO, Burden AD, Capon F, Trembath RC, Barker JN. Mutations in IL36RN/IL1F5 are associated with the severe episodic inflammatory skin disease known as generalized pustular psoriasis. Am J Hum Genet. 2011;89:432–437. - PMC - PubMed
-
- Martins GA, Arruda L. Systemic treatment of psoriasis. Part I. Methotrexate and acitretin. An Bras Dermatol. 2004;79:263–278.
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources